GlassScriptPhysician profile
Melissa R Barber
NPI 1275099657
$11,971.84
in general payments reported to CMS, 2019-2025
38 companies · $3,846 in 2025
The $3,846 reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,741 · 2022: $822 · 2023: $2,953 · 2024: $2,609 · 2025: $3,846.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,409.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,408.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $2,778.51 | 2021-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,957.12 | 2021-2025 | Fasenra, Breztri, Tezspire |
| Genzyme Corporation | $1,412.99 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $1,297.06 | 2023-2025 | Dupixent |
| Mylan Specialty L.P. | $901.54 | 2021-2024 | Yupelri, Yupelri |
| Baxter Healthcare | $709.83 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Actelion Pharmaceuticals US, INC. | $312.78 | 2023-2025 | Uptravi, Opsumit |
| Verona Pharma, INC. | $266.75 | 2025 | Ohtuvayre |
| Janssen Pharmaceuticals, INC | $251.70 | 2024-2025 | Spravato |
| Viatris Specialty LLC | $239.59 | 2025 | Yupelri |
| Novartis Pharmaceuticals Corporation | $191.25 | 2021-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $152.15 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $149.16 | 2023-2025 | Winrevair |
| Grifols USA, LLC | $147.52 | 2024-2025 | Prolastin-C Liquid |
| Harmony Biosciences LLC | $135.70 | 2023-2024 | Wakix |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $119.20 | 2021-2024 | |
| Insmed, INC. | $115.83 | 2024-2025 | Arikayce, Brinsupri |
| Abbvie INC. | $100.62 | 2025 | |
| Electromed, INC. | $100.09 | 2021-2025 | Smartvest |
| Amgen INC. | $84.88 | 2024-2025 | Tezspire |
| Boston Scientific Corporation | $69.29 | 2023 | Resonate El Icd Vr |
| Advanced Respiratory, INC | $69.24 | 2021 | |
| Mayne Pharma Commercial LLC | $61.37 | 2021 | |
| Astellas Pharma US INC | $42.97 | 2021 | |
| Jazz Pharmaceuticals INC. | $40.76 | 2023 | |
| Axsome Therapeutics, INC. | $38.25 | 2023-2025 | Sunosi |
| Lilly USA, LLC | $36.77 | 2025 | Zepbound |
| Sunovion Pharmaceuticals INC. | $27.31 | 2021 | |
| Ethicon INC. | $23.53 | 2022 | |
| Pulmonx Corporation | $21.87 | 2023 | Chartis Catheter, Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console |
| Exact Sciences Corporation | $16.98 | 2023 | Cologuard Collection Kit |
| Phadia US INC. | $16.50 | 2021 | |
| Pfizer INC. | $16.39 | 2023 | |
| Inspire Medical Systems, INC. | $14.94 | 2024 | Inspire |
| Inogen, INC. | $13.75 | 2023 | Inogen One G3 Oxygen Concentrator |
| Philips North America LLC | $13.62 | 2023 | |
| Teva Pharmaceuticals USA, INC. | $12.51 | 2021 | |
| Iovance Biotherapeutics, INC. | $11.52 | 2025 | Amtagvi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Barber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.